Annual accounts receivable:
$33.62M+$3.03M(+9.89%)Summary
- As of today (August 29, 2025), ABCL annual accounts receivable is $33.62 million, with the most recent change of +$3.03 million (+9.89%) on December 31, 2024.
- During the last 3 years, ABCL annual accounts receivable has fallen by -$126.96 million (-79.07%).
- ABCL annual accounts receivable is now -84.24% below its all-time high of $213.24 million, reached on December 31, 2020.
Performance
ABCL Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$47.31M+$7.30M(+18.26%)Summary
- As of today (August 29, 2025), ABCL quarterly accounts receivable is $47.31 million, with the most recent change of +$7.30 million (+18.26%) on June 1, 2025.
- Over the past year, ABCL quarterly accounts receivable has increased by +$11.17 million (+30.90%).
- ABCL quarterly accounts receivable is now -85.85% below its all-time high of $334.40 million, reached on March 31, 2022.
Performance
ABCL Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ABCL Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | +30.9% |
| 3 y3 years | -79.1% | -10.4% |
| 5 y5 years | +1482.7% | +10000.0% |
ABCL Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.1% | +9.9% | -55.4% | +136.5% |
| 5 y | 5-year | -84.2% | +1482.7% | -85.8% | >+9999.0% |
| alltime | all time | -84.2% | +5544.1% | -85.8% | >+9999.0% |
ABCL Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $47.31M(+18.3%) |
| Mar 2025 | - | $40.01M(+19.0%) |
| Dec 2024 | $33.62M(+9.9%) | $33.62M(+7.1%) |
| Sep 2024 | - | $31.37M(-13.2%) |
| Jun 2024 | - | $36.14M(+5.0%) |
| Mar 2024 | - | $34.42M(+12.5%) |
| Dec 2023 | $30.59M(-20.7%) | $30.59M(-18.3%) |
| Sep 2023 | - | $37.45M(-18.0%) |
| Jun 2023 | - | $45.68M(+128.4%) |
| Mar 2023 | - | $20.00M(-48.2%) |
| Dec 2022 | $38.59M | $38.59M(-63.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $105.96M(+100.7%) |
| Jun 2022 | - | $52.80M(-84.2%) |
| Mar 2022 | - | $334.40M(+108.3%) |
| Dec 2021 | $160.58M(-24.7%) | $160.58M(+268.0%) |
| Sep 2021 | - | $43.63M(+1458.9%) |
| Jun 2021 | - | $2.80M(-88.0%) |
| Mar 2021 | - | $23.37M(+2488.2%) |
| Dec 2020 | $213.24M(>+9900.0%) | $903.00K(-83.7%) |
| Sep 2020 | - | $5.53M(+1792.3%) |
| Jun 2020 | - | $292.30K(-86.2%) |
| Dec 2019 | $2.12M(+256.6%) | $2.12M |
| Dec 2018 | $595.60K | - |
FAQ
- What is AbCellera Biologics Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual accounts receivable year-on-year change?
- What is AbCellera Biologics Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly accounts receivable year-on-year change?
What is AbCellera Biologics Inc. annual accounts receivable?
The current annual accounts receivable of ABCL is $33.62M
What is the all time high annual accounts receivable for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual accounts receivable is $213.24M
What is AbCellera Biologics Inc. annual accounts receivable year-on-year change?
Over the past year, ABCL annual accounts receivable has changed by +$3.03M (+9.89%)
What is AbCellera Biologics Inc. quarterly accounts receivable?
The current quarterly accounts receivable of ABCL is $47.31M
What is the all time high quarterly accounts receivable for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly accounts receivable is $334.40M
What is AbCellera Biologics Inc. quarterly accounts receivable year-on-year change?
Over the past year, ABCL quarterly accounts receivable has changed by +$11.17M (+30.90%)